EUVIMEDEUVIMED entdecken
Querschnittstudie

Serosurvey of Visceral Leishmaniasis Among Drug Users in Fars Province, Southern Iran: A Cross-sectional Analysis

Mahshid Dehghani, Mina Zarrabi, Sara Shahriarirad, Sahel Rohampour, Ghazal Shayan, Mostafa Omidian, Jamal Sarvari, Elham Rezaee, Abolfazl Gheshlaghi, Bahador Sarkari

Avicenna Journal of Clinical Microbiology and Infection · 23.02.2026 · 13 (1) · 37-41

DOI: 10.34172/ajcmi.3638 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Avicenna Journal of Clinical Microbiology and Infection, online erschienen am 23.02.2026. Verfasst von Mahshid Dehghani und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug addiction is known to compromise the immune system, thereby increasing susceptibility to infectious diseases. However, the status of visceral leishmaniasis (VL) among drug users, a high-risk group, has not been well understood yet. Therefore, this study aimed to explore the seroepidemiology of VL among drug users in Fars Province, southern Iran.

Methods

This cross-sectional study analyzed 1,400 serum samples from drug users in Fars Province for anti-Leishmania antibodies using a homemade enzyme-linked immunosorbent assay method. The data collected during sampling were documented in a questionnaire and analyzed with SPSS (version 27).

Results

The mean age of the participants was 44.59 (±12.50) years, with 52.7% aged between 40 and 50 years. Anti-Leishmania antibodies were detected in the sera of 27 (1.9%) of the subjects, predominantly in males (92.6%). No significant gender difference was observed in the presence of antibodies. Additionally, seroprevalence did not noticeably differ between injecting and non-injecting drug users. Eventually, the majority of seropositive individuals were under the age of 20 years (18.2%, n=11), highlighting a higher burden among younger participants.

Conclusion

The findings revealed a significant prevalence of VL among drug users in Fars Province, indicating the importance of tailored public health initiatives and additional studies to support this at-risk group.

Zitieren

APA

Dehghani, M., Zarrabi, M., Shahriarirad, S., Rohampour, S., Shayan, G., Omidian, M., Sarvari, J., Rezaee, E., Gheshlaghi, A., & Sarkari, B. (2026). Serosurvey of Visceral Leishmaniasis Among Drug Users in Fars Province, Southern Iran: A Cross-sectional Analysis. Avicenna Journal of Clinical Microbiology and Infection, 13(1), 37-41. https://doi.org/10.34172/ajcmi.3638

Vancouver

Dehghani M, Zarrabi M, Shahriarirad S, Rohampour S, Shayan G, Omidian M, et al. Serosurvey of Visceral Leishmaniasis Among Drug Users in Fars Province, Southern Iran: A Cross-sectional Analysis. Avicenna Journal of Clinical Microbiology and Infection. 2026;13(1):37-41. doi:10.34172/ajcmi.3638

BibTeX
@article{Dehghani2026,
  author = {Dehghani, Mahshid and Zarrabi, Mina and Shahriarirad, Sara and Rohampour, Sahel and Shayan, Ghazal and Omidian, Mostafa and Sarvari, Jamal and Rezaee, Elham and Gheshlaghi, Abolfazl and Sarkari, Bahador},
  title = {Serosurvey of Visceral Leishmaniasis Among Drug Users in Fars Province, Southern Iran: A Cross-sectional Analysis},
  journal = {Avicenna Journal of Clinical Microbiology and Infection},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {37--41},
  doi = {10.34172/ajcmi.3638}
}
Kostenlos starten →